Decreased hepatic ischemia-reperfusion injury by manganese-porphyrin complexes

Free Radical Research

Volumn 41, Issue 2, 2007, Pages 127-134

  Wu, Tzong Jin ^a   Khoo, Nicholas H ^b   Zhou, Fen ^b   Day, Brian J ^c   Parks, Dale A ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; LACTATE DEHYDROGENASE; MANGANESE; MANGANESE TETRAKIS(ETHOXYCARBONYL)PORPHYRIN; MANGANESE TETRAKIS(N ETHYL 2 PYRIDYL)PORPHYRIN; MANGANESE TETRAKIS(N METHYL 2 PYRIDYL)PORPHYRIN; MESOPORPHYRIN; METALLOPORPHYRIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; 3-NITROTYROSINE; ANTIOXIDANT; DRUG DERIVATIVE; MANGANESE TETRAKIS (ETHOXYCARBONYL) PORPHYRIN; MANGANESE TETRAKIS (N ETHYL 2 PYRIDYL) PORPHYRIN; MANGANESE TETRAKIS (N METHYL 2 PYRIDYL) PORPHYRIN; MANGANESE TETRAKIS-(ETHOXYCARBONYL) PORPHYRIN; MANGANESE TETRAKIS-(N-ETHYL-2 PYRIDYL) PORPHYRIN; MANGANESE TETRAKIS-(N-METHYL-2 PYRIDYL) PORPHYRIN; REACTIVE OXYGEN METABOLITE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CATALYSIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME ANALYSIS; ISOLATED LIVER; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; MALE; NITRATION; NONHUMAN; REPERFUSION INJURY; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; ISCHEMIA; LIPID PEROXIDATION; LIVER; LIVER DISEASE; METABOLISM; MOUSE; NITROSATION; SECRETION; VASCULARIZATION;

RATTUS;

ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ISCHEMIA; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; LIVER; LIVER DISEASES; MALE; METALLOPORPHYRINS; MICE; MICE, INBRED C57BL; NITROSATION; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TYROSINE;

EID: 34250896726     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760600801298     Document Type: Article

References (52)

1. Jaeschke, H. (1998) Mechanisms of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreat Surg, 5, pp. 402-408.
2. Fan, C., Zwacka, RM and Engelhardt, JF (1999) Therapeutic approaches for ischemia/reperfusion injury in the liver. J Mol Med, 77, pp. 577-592.
3. Lentsch, AB, Kato, A., Yoshidome, H., McMasters, KM and Edwards, MJ (2000) Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology, 32, pp. 169-173.
4. Serracino-Inglott, F., Habib, NA and Mathie, RT (2001) Hepatic ischemia-reperfusion injury. Am J Surg, 181, pp. 160-166.
5. Isobe, M., Katsuramaki, T., Hirata, K., Kimura, H., Nagayama, M. and Matsuno, T. (1999) Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. Transplantation, 68, pp. 803-813.
6. Nauta, RJ, Tsimoyiannis, E., Uribe, M., Walsh, DB, Miller, D. and Butterfield, A. (1990) Oxygen-derived free radicals in hepatic ischemia and reperfusion injury in the rat. Surg Gynecol Obstet, 171, pp. 120-125.
7. Marterre Jr, WF, Kindy, MS, Carney, JM, Landrum, RW and Strodel, WE (1991) Induction of the protooncogene c-fos and recovery of cytosolic adenosine triphosphate in reperfused liver after transient warm ischemia: Effect of nitrone free-radical spin-trap agents. Surgery, 110, pp. 184-191.
8. Chavez-Cartaya, R., Jamieson, NV, Ramirez, P., Marin, J. and Pino-Chavez, G. (1999) Free radical scavengers to prevent reperfusion injury following experimental warm liver ischaemia. Is there a real physiological benefit?. Transpl Int, 12, pp. 213-221.
9. Nguyen, WD, Kim, DH, Alam, HB, Provido, HS and Kirkpatrick, JR (1999) Polyethylene glycol-superoxide dismutase inhibits lipid peroxidation in hepatic ischemia/reperfusion injury. Crit Care, 3, pp. 127-130.
10. Yokota, R., Fukai, M., Shimamura, T., Suzuki, T., Watanabe, Y., Nagashima, K., Kishida, A., Furukawa, H., Hayashi, T. and Todo, S. (2000) A novel hydroxyl radical scavenger, nicaraven, protects the liver from warm ischemia and reperfusion injury. Surgery, 127, pp. 661-669.
11. Bailey, SM and Reinke, LA (2000) Antioxidants and gadolinium chloride attenuate hepatic parenchymal and endothelial cell injury induced by low flow ischemia and reperfusion in perfused rat livers. Free Radic Res, 32, pp. 497-506.
12. Ejiri, S., Eguchi, Y., Kishida, A., Kurumi, Y., Tani, T. and Kodama, M. (2000) Protective effect of OPC-6535, a superoxide anion production inhibitor, on liver grafts subjected to warm ischemia during porcine liver transplantation. Transplant Proc, 32, pp. 318-321.
13. Ilhan, N., Halifeoglu, I., Ozercan, HI and Ilhan, N. (2001) Tissue malondialdehyde and adenosine triphosphatase level after experimental liver ischaemia-reperfusion damage. Cell Biochem Funct, 19, pp. 207-212.
14. Yabe, Y., Kobayashi, N., Nishihashi, T., Takahashi, R., Nishikawa, M., Takakura, Y. and Hashida, M. (2001) Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther, 298, pp. 894-899.
15. Minor, T., Chung, CW, Yamamoto, Y., Obara, M., Saad, S. and Isselhard, W. (1992) Evaluation of antioxidant treatment with superoxide dismutase in rat liver transplantation after warm ischemia. Eur Surg Res, 24, pp. 333-338.
16. Takayama, F., Egashira, T., Kudo, Y. and Yamanaka, Y. (1993) Effects of anti-free radical interventions on phosphatidylcholine hydroperoxide in plasma after ischemia- reperfusion in the liver of rats. Biochem Pharmacol, 46, pp. 1749-1757.
17. Suzuki, M., Takeuchi, H., Kakita, T., Unno, M., Katayose, Y. and Matsuno, S. (2000) The involvement of the intracellular superoxide production system in hepatic ischemia-reperfusion injury. In vivo and in vitro experiments using transgenic mice manifesting excessive CuZn-SOD activity. Free Radic Biol Med, 29, pp. 756-763.
18. Sugawara, T., Noshita, N., Lewen, A., Gasche, Y., Ferrand-Drake, M., Fujimura, M., Morita-Fujimura, Y. and Chan, PH (2002) Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J Neurosci, 22, pp. 209-217.
19. Lehmann, TG, Wheeler, MD, Schoonhoven, R., Bunzendahl, H., Samulski, RJ and Thurman, RG (2000) Delivery of Cu/Zn-superoxide dismutase genes with a viral vector minimizes liver injury and improves survival after liver transplantation in the rat. Transplantation, 69, pp. 1051-1057.
20. Yin, M., Wheeler, MD, Connor, HD, Zhong, Z., Bunzendahl, H., Dikalova, A., Samulski, RJ, Schoonhoven, R., Mason, RP, Swenberg, JA and Thurman, RG (2001) Cu/Zn-superoxide dismutase gene attenuates ischemia-reperfusion injury in the rat kidney. J Am Soc Nephrol, 12, pp. 2691-2700.
21. Bolli, R., Qiu, Y., Tang, XL, Guo, Y. and French, BA (2001) Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation, 103, pp. 1893-1898.
22. Day, BJ (2004) Catalytic antioxidants: A radical approach to new therapeutics. Drug Discov Today, 9, pp. 557-566.
23. Patel, M. and Day, BJ (1999) Metalloporphyrin class of therapeutic catalytic antioxidants. Trends Pharmacol Sci, 20, pp. 359-364.
24. Ye, YZ, Strong, M., Huang, ZQ and Beckman, JS (1996) Antibodies that recognize nitrotyrosine. Methods Enzymol, 269, pp. 201-209.
25. McCord, JM and Fridovich, I. (1968) The reduction of cytochrome c by milk xanthine oxidase. J Biol Chem, 243, pp. 5733-5737.
26. Day, BJ, Fridovich, I. and Crapo, JD (1997) Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch Biochem Biophys, 347, pp. 256-262.
27. Day, BJ, Batinic-Haberle, I. and Crapo, JD (1999) Metalloporphyrins are potent inhibitors of lipid peroxidation. Free Radic Biol Med, 26, pp. 730-736.
28. Henry, RJ, Chiamori, N., Golub, OJ and Berkman, S. (1960) Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. Am J Clin Pathol, 34, pp. 381-398.
29. MacMillan-Crow, LA, Crow, JP, Kerby, JD, Beckman, JS and Thompson, JA (1996) Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA, 93, pp. 11853-11858.
30. Ross, AD, Sheng, H., Warner, DS, Piantadosi, CA, Batinic-Haberle, I., Day, BJ and Crapo, JD (2002) Hemodynamic effects of metalloporphyrin catalytic antioxidants: Structure-activity relationships and species specificity. Free Radic Biol Med, 33, pp. 1657-1669.
31. Sheng, H., Enghild, JJ, Bowler, R., Patel, M., Batinic-Haberle, I., Calvi, CL, Day, BJ, Pearlstein, RD, Crapo, JD and Warner, DS (2002) Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia. Free Radic Biol Med, 33, pp. 947-961.
32. Trova, MP, Gauuan, PJ, Pechulis, AD, Bubb, SM, Bocckino, SB, Crapo, JD and Day, BJ (2003) Superoxide dismutase mimetics. Part 2: Synthesis and structure-activity relationship of glyoxylate-and glyoxamide-derived metalloporphyrins. Bioorg Med Chem, 11, pp. 2695-2707.
33. Batinic-Haberle, I., Spasojevic, I., Hambright, P., Benov, L., Crumbliss, AL and Fridovich, I. (1999) Relationship among redox potentials, proton dissociation constants of pyrrolic nitrogens, and in vivo and in vitro superoxide dismutating activities of manganese(III) and iron(III) water-soluble porphyrins. Inorg Chem, 38, pp. 4011-4022.
34. Sheng, H., Enghild, JJ, Bowler, R., Patel, M., Batinic-Haberle, I., Calvi, CL, Day, BJ, Pearlstein, RD, Crapo, JD and Warner, DS (2002) Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia. Free Radic Biol Med, 33, pp. 947-961.
35. Mackensen, GB, Patel, M., Sheng, H., Calvi, CL, Batinic-Haberle, I., Day, BJ, Liang, LP, Fridovich, I., Crapo, JD, Pearlstein, RD and Warner, DS (2001) Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant. J Neurosci, 21, pp. 4582-4592.
36. Yuan, GJ, Ma, JC, Gong, ZJ, Sun, XM and Zheng, SH (2005) Modulation of liver oxidant-antioxidant system by ischemic preconditioning during ischemia/reperfusion injury in rats. World J Gastroenterol, 11, pp. 1825-1828.
37. Lubbers, NL, Polakowski, JS, Crapo, JD, Wegner, CD and Cox, BF (2003) Preischemic and postischemic administration of AEOL10113 reduces infarct size in a rat model of myocardial ischemia and reperfusion. J Cardiovasc Pharmacol, 41, pp. 714-719.
38. Sheng, H., Enghild, JJ, Bowler, R., Patel, M., Batinic-Haberle, I., Calvi, CL, Day, BJ, Pearlstein, RD, Crapo, JD and Warner, DS (2002) Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia. Free Radic Biol Med, 33, pp. 947-961.
39. Mackensen, GB, Patel, M., Sheng, H., Calvi, CL, Batinic-Haberle, I., Day, BJ, Liang, LP, Fridovich, I., Crapo, JD, Pearlstein, RD and Warner, DS (2001) Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant. J Neurosci, 21, pp. 4582-4592.
40. Chen, T., Zamora, R., Zuckerbraun, B. and Billiar, TR (2003) Role of nitric oxide in liver injury. Curr Mol Med, 3, pp. 519-526.
41. Hines, IN, Harada, H., Flores, S., Gao, B., McCord, JM and Grisham, MB (2005) Endothelial nitric oxide synthase protects the post-ischemic liver: Potential interactions with superoxide. Biomed Pharmacother, 59, pp. 183-189.
42. Serracino-Inglott, F., Virlos, IT, Habib, NA, Williamson, RC and Mathie, RT (2003) Differential nitric oxide synthase expression during hepatic ischemia-reperfusion. Am J Surg, 185, pp. 589-595.
43. Beckman, JS (2002) Protein tyrosine nitration and peroxynitrite. FASEB J, 16, p. 1144.
44. Trostchansky, A., Ferrer-Sueta, G., Batthyany, C., Botti, H., Batinic-Haberle, I., Radi, R. and Rubbo, H. (2003) Peroxynitrite flux-mediated LDL oxidation is inhibited by manganese porphyrins in the presence of uric acid. Free Radic Biol Med, 35, pp. 1293-1300.
45. Ferrer-Sueta, G., Batinic-Haberle, I., Spasojevic, I., Fridovich, I. and Radi, R. (1999) Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants. Chem Res Toxicol, 12, pp. 442-449.
46. Crow, JP and Beckman, JS (1996) The importance of superoxide in nitric oxide-dependent toxicity: Evidence for peroxynitrite-mediated injury. Adv Exp Med Biol, 387, pp. 147-161.
47. Crow, JP (1999) Manganese and iron porphyrins catalyze peroxynitrite decomposition and simultaneously increase nitration and oxidant yield: Implications for their use as peroxynitrite scavengers in vivo. Arch Biochem Biophys, 371, pp. 41-52.
48. Kachadourian, R., Johnson, CA, Min, E., Spasojevic, I. and Day, BJ (2004) Flavin-dependent antioxidant properties of a new series of meso-N,N'-dialkyl-imidazolium substituted manganese(III) porphyrins. Biochem Pharmacol, 67, pp. 77-85.
49. Day, BJ and Kariya, C. (2005) A novel class of cytochrome P450 reductase redox cyclers: Cationic manganoporphyrins. Toxicol Sci, 85, pp. 713-719.
50. Crow, JP (2000) Peroxynitrite scavenging by metalloporphyrins and thiolates. Free Radic Biol Med, 28, pp. 1487-1494.
51. Bloodsworth, A., O'Donnell, VB, Batinic-Haberle, I., Chumley, PH, Hurt, JB, Day, BJ, Crow, JP and Freeman, BA (2000) Manganese-porphyrin reactions with lipids and lipoproteins. Free Radic Biol Med, 28, pp. 1017-1029.
52. Patel, M. and Day, J. (1999) Metalloporphyrin class of therapeutic catalytic antioxidants. Trends Pharmacol Sci, 20, pp. 359-364.